Home » Orthopedic Oncology Treatment Market

Orthopedic Oncology Treatment Market By Type Of Procedure (Soft Tissue Excisions/Resections, Limb Salvage Surgery, Amputation, Adjuvant Chemotherapy, Reconstructive Surgery) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2023

Price: $4999

Published: | Report ID: 8246 | Report Format : PDF

Market Insights:

Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to the fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of the musculoskeletal system, which include trauma, the spine, the hand, and upper extremity, total joints, and even pediatric orthopedics.

The report titled “Orthopedic Oncology Treatment Market: Growth, Share, Opportunities, and Competitive Analysis, 2016–2023″ offers strategic insights into the overall orthopedic oncology treatment market, along with the market size and estimates for the duration of 2016 to 2023. The said research study covers an in-depth analysis of multiple market segments based on types of procedures and different geographical regions. The procedure type segments studied for analyzing the overall orthopedic oncology treatment market are soft tissue excisions and resections, limb salvage surgery, amputation, adjuvant chemotherapy, and reconstructive surgery. Reconstructive surgery holds the largest share in the global orthopedic oncology market owing to the developments in prosthetics and bone grafting techniques that are being accepted by patients. The limb salvage surgery market is expected to grow at a subtle rate due to its cost-effective nature, so the adjuvant chemotherapy segment would grow at a steady rate.

In order to help strategic decision-makers, the report also includes competitive profiling of the leading players in the orthopedic oncology treatment market and attractive investment propositions and market positioning of key manufacturers sections.

The market size and forecast for these regional and country-level markets are presented in this study for the period 2013–2023. Market growth rates for the forecast period 2016–2023 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global orthopedic oncology treatment market. Tools such as the market positioning of key players and attractive investment propositions provide the readers with insights into the competitive scenario of the global orthopedic oncology treatment market. This report concludes with a company profiles section that highlights major information about the key players engaged in the orthopedic oncology treatment market. In-depth competitive environment analysis and historical years (2013 and 2014) of market size data are also provided in the report.

Thus, the research study provides a holistic view of the global orthopedic oncology treatment market, offering market size and estimates for the period from 2016 to 2023, keeping in mind the above-mentioned factors.

Based on the types of procedures, the global orthopedic oncology treatment market is segmented as follows:

  • Soft-tissue excisions and resections
  • Limb salvage surgery
  • Amputation
  • Adjuvant Chemotherapy
  • Reconstructive Surgery
  • Hip and Joint Replacement
  • Bone Grafts

Orthopedic oncology accounts for a very small percentage in the field of orthopedics due to the fact that the incidences of bone and soft tissue tumors are rare as compared to the benign tumors of the musculoskeletal system, which include trauma, the spine, the hand, and upper extremity, total joints, and even pediatric orthopedics. However, the field of orthopedic oncology continues to be invigorated by exhilarating research and developments that have enhanced the level of treatment and care for patients with various bone and soft-tissue tumors. Currently, most patients with primary bone sarcomas are offered limb-salvage surgery without increasing the risk of survival at the sarcoma centers. Moreover, the advances in imaging techniques and surgical techniques have further improved the treatment of patients with bone and soft-tissue malignancies. Orthopedic oncologists continue to collaborate with other subspecialists to integrate advances in surgical techniques. This is especially true for the development of implants and image-guided surgery.

The global orthopedic oncology treatment market has been segmented by type of procedure into soft tissue excisions and resections, limb salvage surgery, amputation, adjuvant chemotherapy, and reconstructive surgery. The reconstructive surgery is further sub-segmented into hip and joint replacement and bone grafts. Reconstructive surgery has the largest share of the global orthopedic oncology treatment market. The bone grafting techniques are anticipated to grow at the highest rate during the forecast period owing to the advances in the fields of prosthesis and endoprosthesis.

For the purpose of this study, the global orthopedic oncology treatment market is categorized as follows:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

For the purpose of this study, the global orthopedic oncology treatment market is categorized into six regional markets: North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In the base year of 2015, Asia Pacific was observed as the largest market for orthopedic oncology. Large disease prevalence, along with the growing healthcare ecosystem in the region, have assisted the growth of the orthopedic oncology market in Asia-Pacific. Moreover, growth in the medical tourism industry in the region in the last decade has further fueled the market for orthopedic oncology treatment in Asia-Pacific. Cancer incidence and mortality have been increasing in China, making cancer the leading cause of death since 2010 and a major public health problem in the country. In India, the incidence of bone cancer is 1/100 of all cancer cases, but it contributes to about 6–7% of pediatric cancer patients. Latin America, the Middle East, and Africa have emerged as the most potential markets due to the high prevalence of osteosarcoma and the lower treatment options available in the region. Hence, these markets would exhibit a strong growth rate during the forecast period with the development of the healthcare infrastructure.

Chapter 1 Preface 8
1.1 Report Description 8
1.1.1 Purpose of the Report 8
1.1.2 Target Audience 8
1.1.3 USP and Key Offerings 8
1.2 Research Scope 9
1.3 Research Methodology 10
1.3.1 Phase I – Secondary Research 10
1.3.2 Phase II – Primary Research 11
1.3.3 Phase III – Expert Panel Review 11
1.3.4 Assumptions 12

Chapter 2 Executive Summary 13
2.1 Global Orthopedic Oncology Treatment Market Portraiture 14
2.2 Global Orthopedic Oncology Treatment Market, by Procedure Type (USD Mn) 14
2.1 Global Orthopedic Oncology Treatment Market, by Geography (USD Mn) 15

Chapter 3 Global Orthopedic Oncology Treatment Market Analysis 17
3.1 Global Orthopedic Oncology Market Overview 17
3.2 Orthopedic Oncology Treatment Market: Disease Prevalence and Incidence by Continents 18
3.3 Orthopedic Oncology Treatment Market: Future Prospects & Trends 19
3.4 Market Dynamics 20
3.4.1 Drivers 20
3.4.1.1 Impressive Evolution of Bone Targeted Treatment of Cancer 20
3.4.2 Challenges 21
3.4.2.1 Lack of Specialized Orthopaedic Oncologists 21
3.4.2.2 Lack of Awareness about Bone, Soft Tissue and
Musculoskeletal Malignancies 21
3.4.3 Opportunities 22
3.4.3.1 Technological Advancement and Collaboration with Other Sub-specialties 22
3.5 Attractive Investment Proposition 23
3.6 Market Positioning Analysis of Key Players in Orthopedic Oncology Treatment Market 24

Chapter 4 Global Orthopedic Oncology Treatment Market Analysis, by Type of Procedure 26
4.1 Introduction 26
4.2 Soft Tissue Excisions/Resections 27
4.3 Limb Salvage Surgery 28
4.4 Amputation 30
4.5 Adjuvant Chemotherapy 31
4.6 Reconstructive Surgery 32
4.6.1 Hip & Joint Replacement 33
4.6.2 Bone Grafts 34

Chapter 5 Global Orthopedic Oncology Treatment Market, By Geography 36
5.1 Preface 36
5.2 North America (U.S. & Canada) 37
5.3 Europe (U.K., Germany & Rest of Europe) 38
5.4 Asia Pacific (China, Japan and Rest of APAC) 39
5.5 Latin America (Mexico, Brazil and Rest of LATAM) 41
5.6 Middle East and Africa 42

Chapter 6 Company Profiles 44
6.1 Stryker Corporation 44
6.2 Zimmer Biomet Holdings, Inc. 46
6.3 Smith & Nephew plc 49
6.4 DePuy Synthes (Johnson & Johnson) 51
6.5 Medtronic 53
6.6 Accentus Medical 54
6.7 Roche Holding AG 55
6.8 Amgen, Inc. 57
6.9 Novartis AG 59
6.10 GlaxoSmithKline 61
6.11 Sanofi 62
6.12 Pfizer Inc. 64

List of Figures

FIG. 1 Orthopedic Oncology Treatment Market: Research Methodology 10
FIG. 2 Global Orthopedic Oncology Treatment Market, by Procedure Type, 2015 (USD Mn) 14
FIG. 3 Global Orthopedic Oncology Market, by Geography, 2015 (USD Mn) 15
FIG. 4 Disease Prevalence and Incidence by Continents 18
FIG. 5 Attractive Investment Proposition: Global Orthopedic Oncology Treatment Market, by Geography 24
FIG. 6 Market Positioning Analysis of Key Vendors in Orthopedic Oncology Treatment Market 25
FIG. 7 Soft Tissue Excisions/Resections Market, 2013 – 2023 (USD Mn) 28
FIG. 8 Limb Salvage Surgery Market, 2013 – 2023 (USD Mn) 29
FIG. 9 Amputation Market, 2013 – 2023 (USD Mn) 30
FIG. 10 Adjuvant Chemotherapy Market, 2013 – 2023 (USD Mn) 32
FIG. 11 Hip & Joint Replacement Surgery Market, 2013 – 2023 (USD Mn) 34
FIG. 12 Bone Grafts Market, 2013 – 2023 (USD Mn) 35
FIG. 13 North America Orthopedic Oncology Treatment Market , by Country, 2013 – 2023 (USD Mn) 38
FIG. 14 Europe Orthopedic Oncology Treatment Market , by Country, 2013 – 2023 (USD Mn) 39
FIG. 15 Asia Pacific Orthopedic Oncology Treatment Market , by Country, 2013 – 2023 (USD Mn) 40
FIG. 16 Latin America Orthopedic Oncology Treatment Market , by Country, 2013 – 2023 (USD Mn) 41
FIG. 17 Middle East and Africa Orthopedic Oncology Treatment Market , by Country, 2013 – 2023 (USD Mn) 42

List of Tables

TABLE 1 Global Orthopedic Oncology Treatment Market, by Procedure Type, 2013-2023 (USD Mn) 27
TABLE 2 Global Reconstructive Surgery Market, by Type, 2013-2023 (USD Mn) 33
TABLE 3 Global Orthopedic Oncology Treatment Market, by Geography, 2013 – 2023 (USD Mn) 36
TABLE 4 Stryker Corporation: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 44
TABLE 5 Zimmer Biomet Holdings, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 46
TABLE 6 Smith & Nephew plc: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 49
TABLE 7 DePuy Synthes (Johnson & Johnson): Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 51
TABLE 8 Medtronic: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 53
TABLE 9 Accentus Medical: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 54
TABLE 10 Roche Holding AG: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 55
TABLE 11 Amgen, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 57
TABLE 12 Novartis AG.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 59
TABLE 13 GlaxoSmithKline: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 61
TABLE 14 Sanofi: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 62
TABLE 15 Pfizer Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage) 64

Frequently Asked Questions: 

What is the size of Orthopedic Oncology Treatment Market?

The market for Orthopedic Oncology Treatment Market is expected to reach USD 1.12 Mn in 2023.

What is the Orthopedic Oncology Treatment Market CAGR?

The Orthopedic Oncology Treatment Market is expected to see significant CAGR growth over the coming years, at 1.2%

What is the Forecast period considered for Orthopedic Oncology Treatment Market?

The report is forecasted from 2016-2023.

What is the base year considered for Orthopedic Oncology Treatment Market?

The base year of this report is 2015.

Who are the major players in this market?

Stryker Corporation 44,Zimmer Biomet Holdings, Inc. 46,Smith & Nephew plc 49,DePuy Synthes (Johnson & Johnson) 51,Medtronic 53 are some of the major players in the global market.

MRI Guided Neurosurgical Ablation Market

Published:
Report ID: 33742

Glycated Albumin Assay Market

Published:
Report ID: 33574

Proliferative Diabetic Retinopathy Market

Published:
Report ID: 33536

Endoscopic Ultrasound (EUS) Needles Market

Published:
Report ID: 4131

Healthcare POS Terminals Market

Published:
Report ID: 13903

Optogenetics Market

Published:
Report ID: 8143

Medical Robotics Market

Published:
Report ID: 14075

Ablation Devices Market

Published:
Report ID: 1062

Medical Imaging Reagents Market

Published:
Report ID: 8770

X-Ray Security Screening Market

Published:
Report ID: 9312

Metal Implants and Medical Alloys Market

Published:
Report ID: 32899

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN